Cerity Partners LLC Nuvasive Inc Transaction History

Cerity Partners LLC

$44.7 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$36.81 - $48.12 $16,638 - $21,750	452 New	452 $18,000
Q2 2022 Aug 10, 2022	BUY	$46.84 - $59.75 $190,545 - $243,063	4,068 New	4,068 $200,000
Q1 2022 Apr 25, 2022	SELL	$48.09 - $57.79 $194,379 - $233,587	-4,042 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$47.19 - $62.68 $190,741 - $253,352	4,042 New	4,042 $212,000
Q4 2020 Feb 11, 2021	SELL	$43.41 - $56.51 $9.61 Million - $12.5 Million	-221,388 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$32.82 - $81.13 $628,437 - $1.55 Million	19,148 Added 9.47%	221,388 $11.2 Million
Q4 2019 Feb 14, 2020	SELL	$60.96 - $77.7 $2.28 Million - $2.9 Million	-37,353 Reduced 15.59%	202,240 $15.6 Million
Q3 2019 Oct 30, 2019	SELL	$55.78 - $68.08 $44,233 - $53,987	-793 Reduced 0.33%	239,593 $15.2 Million
Q2 2019 Aug 14, 2019	BUY	$53.69 - $65.47 $2.11 Million - $2.58 Million	39,334 Added 19.56%	240,386 $14.1 Million
Q1 2019 May 14, 2019	BUY	$44.53 - $58.9 $8.52 Million - $11.3 Million	191,432 Added 1989.94%	201,052 $11.4 Million
Q4 2018 Feb 06, 2019	SELL	$47.64 - $71.26 $190 - $285	-4 Reduced 0.04%	9,620 $477,000
Q3 2018 Nov 15, 2018	SELL	$52.03 - $71.41 $284,656 - $390,684	-5,471 Reduced 36.24%	9,624 $683,000
Q2 2018 Aug 15, 2018	BUY	$48.15 - $56.68 $260,732 - $306,922	5,415 Added 55.94%	15,095 $787,000
Q1 2018 May 15, 2018	SELL	$46.03 - $61.28 $1.17 Million - $1.55 Million	-25,319 Reduced 72.34%	9,680 $505,000
Q4 2017 Feb 14, 2018	SELL	$50.58 - $60.79 $1.04 Million - $1.25 Million	-20,524 Reduced 36.96%	34,999 $2.05 Million
Q3 2017 Nov 13, 2017	BUY	$53.54 - $68.0 $2.97 Million - $3.78 Million	55,523	55,523 $3.08 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.

Account